Publications by authors named "Uyen My Bui"
Pneumococcal disease (PD), caused by , is a serious global health issue, primarily for adults over 65, due to its high mortality and morbidity rates. Recently, broader-serotype vaccines have been introduced to cope with tremendous hospital costs and decreasing quality of life. Our study aims to systematically review the cost-effectiveness of current PCVs (pneumococcal conjugate vaccines) and PPVs (pneumococcal polysaccharide vaccine) from 2018 to April 2024.
View Article and Find Full Text PDFArticle Synopsis
- * Our study examines the cost-effectiveness of pneumococcal conjugate vaccines (PCVs) in children, focusing on economic evaluations from the past few years and using Incremental Cost-Effectiveness Ratios (ICER) and Quality-Adjusted Life Years (QALY) for analysis.
- * Findings indicate that while PCV13 and PCV10 are cost-effective compared to no vaccination, transitioning to PCV20 offers even greater health benefits and cost savings over PCV15, making it a preferable option in